S100A4 and nephrolithiasis: Western blotting further confirmed that the protein levels of S100A4, ARPC1B, and CEBPD were significantly upregulated.These results collectively suggest that S100A4, ARPC1B, and CEBPD may serve as core biomarkers in the common mechanisms underlying diabetes and kidney stones (Figure 9).